Literature DB >> 29066575

CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC.

Tim F Greten1, Firouzeh Korangy1.   

Abstract

Entities:  

Keywords:  cell cycle control; hepatocellular carcinoma; immunotherapy

Mesh：

Year:  2017        PMID： 29066575      PMCID： PMC6347020          DOI： 10.1136/gutjnl-2017-315091

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  An approach using Caenorhabditis elegans screening novel targets to suppress tumour cell proliferation.

Authors:  Yu-Qin Mao; San-Feng Han; Shi-Long Zhang; Zheng-Yan Zhang; Chao-Yue Kong; Hui-Ling Chen; Zhan-Ming Li; Pei-Ran Cai; Bing Han; Li-Shun Wang
Journal:  Cell Prolif       Date:  2020-05-25       Impact factor: 6.831

2.  An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma.

Authors:  Hanyong Sun; Weiqin Yang; Yuan Tian; Xuezhen Zeng; Jingying Zhou; Myth T S Mok; Wenshu Tang; Yu Feng; Liangliang Xu; Anthony W H Chan; Joanna H Tong; Yue-Sun Cheung; Paul B S Lai; Hector K S Wang; Shun-Wa Tsang; King-Lau Chow; Mengying Hu; Rihe Liu; Leaf Huang; Bing Yang; Pengyuan Yang; Ka-Fai To; Joseph J Y Sung; Grace L H Wong; Vincent W S Wong; Alfred S L Cheng
Journal:  Nat Commun       Date:  2018-12-06       Impact factor: 14.919

3.  ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.

Authors:  Shirong Zhang; Longwen Xu; Jinteng Feng; Deli Tan; Yue Zhu; Jia Hou; Wenyuan Li; Kejia Lv; Wenjuan Wang; Lili Jiang; Min Jiao; Hui Guo
Journal:  Front Genet       Date:  2022-03-10       Impact factor: 4.599

Review 4.  Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives.

Authors:  Xuezhen Zeng; Simon E Ward; Jingying Zhou; Alfred S L Cheng
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.